It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2002.
2002 | Hyderabad, Telangana, India | ActiveJayanth Pharmaceuticals Private Limited, a active private limited company, was established on 31 January 2002 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG2002PTC038432. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.
It upholds a compliant status. Employing 13 professional, Its leadership includes Ravi Teja Reddy Baireddy (Whole-Time Director), Nitya Dasaram (Whole-Time Director), Koti Reddy Baireddy (Managing Director). Past directors included Sudhakar Reddy Thirugudu, Karunakar Rao Govrineni, Baireddy Jaya. It holds ₹25.19 Cr open charges and ₹12.24 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Pl.No 4A,Phase 1,Ida, Cherlapally, Hyderabad, Telangana, 500051.
U24239TG2002PTC038432
038432
31 January 2002
₹2.00 Cr
₹2.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Jayanth Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravi Teja Reddy Baireddy | Whole-Time Director | 30 Sep 2018 | Current |
| Nitya Dasaram | Whole-Time Director | 30 Sep 2018 | Current |
| Koti Reddy Baireddy | Managing Director | 31 Jan 2002 | Current |
| Baireddy Jaya | Whole-Time Director | 19 May 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 14 May 2016 | Past |
| Pramod Abcsdd | Whole-Time Director | 19 May 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jayanth Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.7% increase. The company also saw a substantial improvement in profitability, with a 100.15% increase in profit. The company's net worth Soared by an impressive increase of 18.5%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Jayanth Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹251,923,000.00
₹122,425,998.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2023 | Indian Bank | ₹8.20 Cr | Open |
| 19 Oct 2022 | Indian Bank | ₹16.88 Cr | Open |
| 31 May 2022 | Hdfc Bank Limited | ₹1.17 M | Open |
| 25 Oct 2021 | Others | ₹3.25 Cr | Satisfied |
| 25 Sep 2021 | Others | ₹1.35 Cr | Satisfied |
Explore comprehensive loan charge details -
Jayanth Pharmaceuticals has a workforce of 13 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Jayanth Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jayanth Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Jayanth Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity A charge registered on 16 Aug 2021 via Charge ID 100471379 with Axis Bank Limited was fully satisfied on 21 Aug 2025. was completed.
Progress on Jayanth Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
A charge registered on 25 Oct 2021 via Charge ID 100500794 with Others was fully satisfied on 24 May 2023. was recorded as a recent event.
Progress on A charge with Indian Bank amounted to Rs. 8.20 Cr with Charge ID 100708403 was registered on 31 Mar 2023. was documented.
A charge with Indian Bank amounted to Rs. 16.88 Cr with Charge ID 100628249 was registered on 19 Oct 2022. was recorded as a recent event.
The CIN of Jayanth Pharmaceuticals Private Limited is U24239TG2002PTC038432.
Jayanth Pharmaceuticals Private Limited is headquartered at Pl.No 4A,Phase 1,Ida, Cherlapally, Hyderabad, Telangana, 500051.
Jayanth Pharmaceuticals Private Limited was incorporated on 31 January 2002.
The current directors of Jayanth Pharmaceuticals Private Limited are
The primary industry of Jayanth Pharmaceuticals Private Limited is Manufacturing.
Jayanth Pharmaceuticals Private Limited is unlisted.
The authorized capital of Jayanth Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Jayanth Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX